Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000628
Filing Date
2024-05-08
Accepted
2024-05-08 13:31:09
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240331x10q.htm   iXBRL 10-Q 1590739
2 EX-31.1 tmb-20240331xex31d1.htm EX-31.1 10572
3 EX-31.2 tmb-20240331xex31d2.htm EX-31.2 11423
4 EX-32.1 tmb-20240331xex32d1.htm EX-32.1 6609
  Complete submission text file 0001410578-24-000628.txt   7550869

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20240331.xsd EX-101.SCH 66656
6 EX-101.CAL tmb-20240331_cal.xml EX-101.CAL 52845
7 EX-101.DEF tmb-20240331_def.xml EX-101.DEF 231742
8 EX-101.LAB tmb-20240331_lab.xml EX-101.LAB 454208
9 EX-101.PRE tmb-20240331_pre.xml EX-101.PRE 398082
79 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240331x10q_htm.xml XML 1195192
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

EIN.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55066 | Film No.: 24925165
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)